FMS freseniusmedicalcare.com: Rasio rega marang prakiraan pendapatan
The forward price-to-sales ratio for Fresenius Medical Care (FMS) demonstrates the evolution of market expectations, where the 0.40 mark indicates the current state of the metric. Previously, stability was maintained through the optimization of cross-border flows and hubs. Currently, growth is driven by global dominance in dialysis via AI analytics and vertical integration, leveraging a network of specialized plants and clinics worldwide.
Rincian analitis perusahaan Fresenius Medical Care
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- indikator nilai buku ekuitas:
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Fresenius Medical Care|FMS - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Fresenius Medical Care|FMS - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Fresenius Medical|FMS - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Fresenius Medical Care|Rasio cepet freseniusmedicalcare.com
- rincian asil keuangan lan kelipatan valuasi:
FMS - Bathi perusahaan|Proyeksi bathi mangsa ngarep Fresenius Medical Care|FMS - Periode bali modal bisnis|Pangali Forward P/E Fresenius Medical Care Corp|FMS - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Fresenius Medical|FMS - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Fresenius Medical Care|FMS - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan freseniusmedicalcare.com|FMS - Tambahing bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Fresenius Medical Care
- indikator volume dodolan lan pendapatan:
Ringkesan analisis perusahaan:FMS (Fresenius Medical Care AG & Co. KGaA)
The optimization of Fresenius Medical Care clinics and the expansion of home dialysis are driving future cash flows, as reflected in the forward price-to-sales multiple chart. This indicator compares current market capitalization with projected sales volume, allowing for a real-time assessment of market expectations without the lag of financial reporting. A declining ratio amid a stable business signals that the asset is undervalued, creating an entry point for long-term investors.
Pesaing Fresenius Medical Care (FMS)
Multiplikator Forward P/S HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|SOLV - Rasio rega marang prakiraan pendapatan|EHC (Encompass) - Kapitalisasi marang prakiraan pendapatan|UHS: Multiplikator Forward P/S|DVA - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan RDNT|Multiplikator Forward P/S Option Care|Rasio rega marang prakiraan pendapatan Surgery Partners Corp (SGRY)|Rasio kapitalisasi marang dodolan sing dikarepake Premier Health|National Vision Holdings - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan PGNY|ARDT - Rasio rega marang prakiraan pendapatan|Select Medical Corporation (SEM) - Multiplikator forward rega marang pendapatan|ASTH: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep MEDNAX (MD)|USPH (US Physical Therapy) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan PNTG (pennantgroup.com)|Multiplikator Forward P/S ORGO|Rasio kapitalisasi marang dodolan sing dikarepake Nutex Health Inc|Multiplikator Forward P/S AUNA (Auna Health)|SBC - Multiplikator forward rega marang pendapatan|Evolus, Inc. - Multiplikator Forward P/S|CYH - Multiplikator Forward P/S|beautyhealth.com (SKIN) - Rasio rega marang prakiraan pendapatan|MDWD (MediWound) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan BTMD|JYNT: Rega forward marang dodolan|Multiplikator Forward P/S DCGO|Multiplikator forward rega marang pendapatan p3hp.org PIII|Multiplikator Forward P/S GANX (Gain Therapeutics)|Multiplikator Forward P/S EUDA Health Holdings EUDA|BMGL - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CLGN (CollPlant Biotechnologies)|CUPR: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Multiplikator Forward P/S|MEDIROM Healthcare Group Inc. - Rega mangsa ngarep marang pendapatan|Rasio rega marang prakiraan pendapatan Avalon GloboCare (ALBT)|Multiplikator forward rega marang pendapatan DIH Group DHAI|Rasio rega marang prakiraan pendapatan Longevity Health Holdings XAGE|Rasio kapitalisasi marang dodolan sing dikarepake newgenivf.com (NIVF)|ATIP: Multiplikator forward rega marang pendapatan|CareMax Inc. - Rasio rega marang pendapatan sing dikarepake|Kindly MD Corp (KDLY) - Rasio rega marang prakiraan pendapatan|ModivCare Corp - Rega forward marang dodolan|NVOS (Novo Integrated Sciences) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep SunLink Health Systems, Inc SSY|Multiplikator Forward P/S BACK
